Navigation Links
Monsanto Declared Worst Company of 2011 by NaturalSociety
Date:12/6/2011

PHILADELPHIA, Dec. 6, 2011 /PRNewswire/ -- Monsanto, a major biotech corporation responsible for genetically modifying many staple foods, has been given the Worst Company of 2011 Award for threatening both human health and the environment. The award was given by natural health information website NaturalSociety after thousands of readers voted Monsanto the worst company of 2011.

Numerous scientific studies have found Monsanto's GMO crops, herbicides, and biopesticides to be a danger to the planet. A review of 19 studies announced that consumption of GMO corn or soybeans may lead to significant organ disruptions in rats and mice – particularly in the liver and kidneys. The researchers also mentioned that GMO soybean and corn varieties contribute to "83% of the commercialized GMOs" that you may currently be consuming if you purchase conventional produce. Monsanto's best-selling herbicide Roundup has also been found to create superweeds that are heavily resistant to herbicides, which are estimated to now consume over 120 million hectares worldwide.

The award is intended to bring awareness to these environmental issues, which are continually being recognized by nations worldwide. Hungary, Peru, and France are among the countries who have spoken out against Monsanto and GMO crops alike. Hungary recently destroyed 1,000 acres of maize found to have been grown with genetically modified seeds, according to Hungary deputy state secretary of the Ministry of Rural Dev
'/>"/>

SOURCE NaturalSociety
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Monsantos Kerry Preete to Address Investors at Goldman Sachs Agricultural Biotech Forum
2. Continued Demand Makes Monsanto and Agriculture Unique Investment Opportunities, Global Seeds and Traits Lead to Tell Investors
3. Monsanto Reconfirms 2010 Guidance and 2012 Financial Commitments on Strength of Larger Expected Launches for Blockbuster Products
4. Monsanto Opens First Biotechnology Research Center in China
5. Monsanto and Huazhong Agricultural University Enter Into Collaboration Focusing on Development of Plant Biotechnology
6. Monsanto Licenses Use of Cellectis Innovative Genome Modification Technology
7. Monsanto Is on the Verge of a Technology Explosion, Executives Tell Investors at Annual Field Event
8. Dow AgroSciences, Monsanto Complete U.S. and Canadian Regulatory Authorizations for SmartStax Corn; Plans Set to Launch Seed Platform on 3 Million- to 4 Million-Plus Acres
9. Monsanto, BASF Scientists Disclose Discovery of Gene Conferring Drought Tolerance in Corn Plants
10. Monsantos Historic R&D Investment has Contributed to Mid-20s Gross Profit Growth for Its Seeds and Genomics Segment
11. Monsanto Executives to Discuss Companys Growth Drivers, Profit Goals at Investor Conferences in February
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... , April 1, 2015  Organovo Holdings, ... company focused on delivering breakthrough 3D bioprinting technology, ... kidney tissue at the 2015 Experimental Biology conference ... "Kidney represents an ideal extension of ... can be tremendously useful in pharmaceutical research," said ...
(Date:4/1/2015)... ROCKVILLE, Md. , April 1, 2015 /PRNewswire/ ... developer of pathogen-specific therapies for serious infections and ... today announced that clinical data supporting the development ... degrade certain beta-lactam intravenous (IV) antibiotics within the ... of the gut microbiome for the prevention of ...
(Date:4/1/2015)... and NEW YORK CITY and ... a leading provider of market research reports and solutions, MarketResearch.com ... indicating that 2015 will be a year of market growth ... executives operating a stem cell company or cord blood bank, ... You must analyze market conditions, predict industry trends, and act ...
(Date:4/1/2015)... National recruitment firm Slone Partners ... as Head of Sales at Optimal Medicine, an international ... , Allen brings over 20 years experience in healthcare ... of companies including Dell Services Healthcare, Medsphere Systems and ... perfect fit for accomplishing the goals Optimal Medicine had ...
Breaking Biology Technology:Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 2Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 3Organovo Describes First Fully Cellular 3D Bioprinted Kidney Tissue 4Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 2Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 3Synthetic Biologics' SYN-004 Clinical Data for Protection of Microbiome Selected for Poster Presentation at American Society of Microbiology 2015 4MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 2MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 3MarketResearch.com: "Blockbuster" Year for Stem Cells Creates Market Opportunities, Says BioInformant Worldwide Report 4Slone Partners Fills Head of Sales at Optimal Medicine 2
... Masimo Corporation,(Nasdaq: MASI ), the inventor of ... to present at the Deutsche Bank 33rd,Annual Health Care ... May 6, 2008 at 9:30 a.m. ET. Joe E. ... of the presentation will be available on the Masimo ...
... first,paragraph. The timing of the live teleconference should have read: "9:00 am ... copy follows: Resverlogix ... ... is pleased to announce that it will host a live,teleconference on May 8, 2008 ...
... to Provide Unique Insights and ... SOUTH SAN FRANCISCO, May 1 Monogram,Biosciences, Inc. ... HER1,and HER3 Quantitative Protein Assays are now available for ... and,HER3 assays provide unique, quantitative measurements of protein expression,and ...
Cached Biology Technology:Masimo to Present at Deutsche Bank 33rd Annual Health Care Conference 2/C O R R E C T I O N from Source -- Resverlogix Corp./ 2HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 2HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 3HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 4HER1 and HER3 VeraTag(TM) Assays are Now Available for Use in Development and Clinical Evaluation of Cancer Therapeutics 5
(Date:3/23/2015)... , March 23, 2015   HOYOS Labs ... management company, today announced that the Company will demonstrate ... both enterprise and consumers at Connect:ID on March 23 ... HOYOS Labs will highlight the IEEE Biometric Open ... ; and enterprise access control system. BOPS was ...
(Date:3/20/2015)... OXFORD, Conn. , March 20, 2015 ... "Company"), a biometric authentication company focused on the growing ... Wocket® smart wallet is one of the products featured ... today, March 20th at 11:00 PM EST on the ... travels to Las Vegas , site ...
(Date:3/17/2015)... March 17, 2015 Emotient, the leader ... today announced general availability of Emotient Analytics ... the analysis of facial expressions. The system analyzes ... content, products and services. It delivers audience response ... sentiment - as derived from facial evidence of ...
Breaking Biology News(10 mins):HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 2NXT-ID's Wocket Biometric Smart Wallet to Air on "I Want That" International CES Special 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 2New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 3New Emotient Web Service Measures Audience Response Using On-Demand Facial Expression Analysis 4
... EAST LANSING, Mich. Researchers at Michigan State University ... natural killer cells fight bacterial infection and reduce inflammation, ... are fiber supplements that serve as food for the ... taken, they can stimulate the growth of the "good" ...
... PhD, research group leader at the new Max Planck ... The Michael J. Fox Foundation for Parkinson,s Research (MJFF). ... to develop a technology that will help scientists working ... LRRK2, a Parkinson,s-related gene. Globally, five million people have ...
... presented at Europe,s leading breast cancer translational research conference ... differences between individual breast cancers. Focused on ... sensitive to important therapies, the new studies will help ... for millions of patients. "Despite major advances in ...
Cached Biology News:Researchers show prebiotic can reduce severity of colitis 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 2Michael J. Fox Foundation grant to Dr. Samuel Young will provide Parkinson's drug development tools 3New data improve understanding of breast cancer's multiple varieties 2New data improve understanding of breast cancer's multiple varieties 3New data improve understanding of breast cancer's multiple varieties 4New data improve understanding of breast cancer's multiple varieties 5New data improve understanding of breast cancer's multiple varieties 6
5X StabilCoat Immunoassay Stabilizer is a 5X concentrate solution of StabilCoat Immunoassay Stabilizer. The shelf-life of 5X StabilCoat Immunoassay Stabilizer is 2 years when stored at 4C. Product ...
Mouse monoclonal antibody to PPP2R2C - protein phosphatase 2 (formerly 2A), regulatory subunit B (PR 52), gamma isoform...
Mouse polyclonal antibody to BTG2 - BTG family, member 2...
...
Biology Products: